Photo - TheraCea Pharma
57380

TheraCea Pharma

USA, Arizona
Market: Medicine, Chemistry
Stage of the project: Prototype or product is ready

Date of last change: 18.05.2022
Show contacts
1
equalizer from 2000
help
Calculated and estimated occupancy of the project (more about ratings)
My rating
1
2
3
4
5
6
7
8
9
10
Average rating:
 

Idea

Clinical product for early assessment of efficacy of immunotherapy drugs to save time, money, and lives.

Current Status

Validation studies in animal and initiating regulatory related activities

Problem or Opportunity

Immunotherapy drugs (cancer vaccines, CAR-T, monoclonal antibodies, and checkpoint inhibitors) are highly effective and promising for the treatment of cancer. But, unfortunately, they only works in less than 20% of the total population of the cancer patients. There is no reliable clinical diagnosis for early assessment of efficacy of immunotherapy treatment, which leads to: 1) a life-threatening delay to adopt alternative treatments, 2) significant cost for the patients and the healthcare system, and 3) inconclusive, longer, and more expensive clinical trials for new immunotherapy products.

Solution (product or service)

TheraCea is developing a clinical diagnostic product for the early assessment of patient response to cancer immunotherapy drugs by Positron Emission Tomography (PET) imaging. This product offers significant technical and economic advantages, access to a large distribution network, and adoptability with the current infrastructure in the industry.

Business model

While the product is in the clinical trials stages, it will be used as a service for other pharmaceutical companies during their clinical trials on immunotherapy product. Later when the product is in the market, it will use to identify the right group of patients for specific immunotherapy drugs

Incubation/Acceleration programs accomplishment

National NSF ICorps program, NIH C3i training, University of Arizona Center for Innovation incubator program
5,00
1
2
3
4
5
1 voice
Sign in/Sign up
arrow_back
EN
more_horiz
close
visibility102
star0
Add to favorites
Delete from favorites
share
close
thumb_up0
Like
Unlike
Idea
Current Status
Market
Problem or Opportunity
Solution (product or service)
Competitors
Advantages or differentiators
Finance
Invested in previous rounds, $
Business model
Money will be spent on
Offer for investor
Team or Management
Mentors & Advisors
Lead investor
Risks
Incubation/Acceleration programs accomplishment
Won the competition and other awards
Invention/Patent
Photos
Product Video